Safety and immunogenicity of a booster dose of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in previously vaccinated healthy adults; a randomized controlled multicentre trial

Glenn Hamonic, Supriya Arora, Ravendra Garg, Erin Scruten, Rachelle Buchanan, Stephanie L. Saundh, Nicolas Collin, Stephen Sanche, Noah Vale, Timothy Salter, Scott A. Halperin, Joanne M. Langley, Volker Gerdts, Trina Racine · 2026

Read Safety and immunogenicity of a booster dose of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in previously vaccinated healthy adults; a randomized controlled multicentre trial by Glenn Hamonic, Supriya Arora, Ravendra Garg, Erin Scruten, Rachelle Buchanan, Stephanie L. Saundh, Nicolas Collin, Stephen Sanche, Noah Vale, Timothy Salter, Scott A. Halperin, Joanne M. Langley, Volker Gerdts, Trina Racine (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13271356.txt.

Description

Glenn Hamonic is lead author of a 2026 randomized multicentre trial of COVAC-2, a COVID-19 booster vaccine made from a lab-built piece of the virus spike protein plus an oil-in-water booster ingredient. The phase 1 trial enrolled healthy adults who had already received authorised COVID-19 vaccines.

Sixty participants received one shot of COVAC-2 at 10 or 25 micrograms, or a placebo, and were followed for 180 days. The vaccine was well tolerated, with mostly mild or moderate reactions and no serious events blamed on it. The 25-microgram dose gave the strongest antibody and T cell responses, peaking at 14 days and staying above starting levels through day 180.

Catalog record

CREATORGlenn Hamonic, Supriya Arora, Ravendra Garg, Erin Scruten, Rachelle Buchanan, Stephanie L. Saundh, Nicolas Collin, Stephen Sanche, Noah Vale, Timothy Salter, Scott A. Halperin, Joanne M. Langley, Volker Gerdts, Trina Racine
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE55396
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13271356

Browse the full library · About the Tower of Babel